RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE

Johnson & Johnson ROE 2024

Johnson & Johnson ROE

0.51

Johnson & Johnson Dividend yield

3.22 %

Ticker

JNJ

ISIN

US4781601046

WKN

853260

In 2024, Johnson & Johnson's return on equity (ROE) was 0.51, a 118.81% increase from the 0.23 ROE in the previous year.

Johnson & Johnson Aktienanalyse

What does Johnson & Johnson do?

Johnson & Johnson is an American company that was founded in 1886 by the brothers Robert, James, and Edward Johnson. The company is headquartered in New Brunswick, New Jersey, USA and is now an internationally operating company with more than 130,000 employees worldwide. The history of Johnson & Johnson began with the production of medical bandages. In 1887, the first self-adhesive wound plaster was invented and patented. In the following years, the product range was significantly expanded and now includes a wide range of health products. This includes pharmaceuticals, medical devices, hygiene products, personal care products, and baby products. The business model of Johnson & Johnson is to improve the lives of people worldwide. The company places great importance on innovation, quality, and sustainability. With its long-standing experience and expertise in the healthcare industry, Johnson & Johnson is able to understand the needs of customers and offer products tailored to their specific needs. Johnson & Johnson is now active in three main business areas: Consumer Health, Medical Devices and Diagnostics, and Pharmaceuticals. Within these business areas, there are a variety of brands and products that are among the most well-known in the world. The Consumer Health division of Johnson & Johnson is focused on the production of health and personal care products for consumers. Some well-known brands in this area include Listerine, Johnson's Baby, Neutrogena, and Nicorette. The company offers a wide range of products, from cold and allergy medications to skincare products and toothpastes. Medical Devices and Diagnostics is another major business area of Johnson & Johnson. The company is a leading provider of medical devices and diagnostic products worldwide. Products in this area include surgical systems, implantable devices, diagnostic tests, and imaging devices. Well-known brands in this area include Ethicon, Depuy Synthes, and Cordis. Pharmaceuticals is the third major business area of Johnson & Johnson. The company develops and produces innovative pharmaceuticals for the treatment of diseases such as cancer, diabetes, heart disease, and neurological disorders. Some well-known brands in this area include Remicade, Invega, and Zytiga. Johnson & Johnson is also known for its commitment to sustainability and corporate social responsibility. The company is committed to having a positive impact on the environment and the communities in which it operates. For example, Johnson & Johnson aims to reduce its CO2 emissions by 60% by 2030. Overall, Johnson & Johnson is a leading healthcare company focused on providing innovative and high-quality products that improve the lives of people worldwide. With a wide range of brands and products in various business areas, the company is well positioned to continue to be successful in the future. Johnson & Johnson ist eines der beliebtesten Unternehmen auf Eulerpool.com.

ROE Details

Decoding Johnson & Johnson's Return on Equity (ROE)

Johnson & Johnson's Return on Equity (ROE) is a fundamental metric evaluating the company's profitability relative to its equity. Calculated by dividing net income by shareholder's equity, ROE illustrates how effectively the company is generating profits from shareholders’ investments. A higher ROE represents enhanced efficiency and profitability.

Year-to-Year Comparison

Analyzing Johnson & Johnson's ROE on a yearly basis aids in tracking its profitability trends and financial performance. An increasing ROE suggests enhanced profitability and value generation for shareholders, whereas a declining ROE may indicate issues in profit generation or equity management.

Impact on Investments

Johnson & Johnson's ROE is instrumental for investors assessing the company's profitability, efficiency, and investment attractiveness. A robust ROE indicates the firm’s adeptness at converting equity investments into profits, thereby enhancing its appeal to potential and current investors.

Interpreting ROE Fluctuations

Changes in Johnson & Johnson’s ROE can emanate from variations in net income, equity capital, or both. These fluctuations are scrutinized to evaluate management’s effectiveness, financial strategies, and the inherent risks and opportunities, aiding investors in making informed decisions.

Frequently Asked Questions about Johnson & Johnson Stock

What is the ROE (Return on Equity) of Johnson & Johnson this year?

The ROE of Johnson & Johnson this year is 0.51 undefined.

How has the Return on Equity (ROE) of Johnson & Johnson developed compared to the previous year?

The ROE of Johnson & Johnson has increased by 118.81% increased compared to the previous year.

What impact does a high ROE (Return on Equity) have on investors of Johnson & Johnson?

A high ROE indicates that Johnson & Johnson generates good returns on capital and is successful in monetizing its investments. This is a positive indicator for investors.

What impact does a low ROE (Return on Equity) have on investors of Johnson & Johnson?

A low ROE can indicate that Johnson & Johnson is having difficulties monetizing its investments successfully and can be a negative signal for investors.

How does a change in the ROE (Return on Equity) of Johnson & Johnson affect the company?

A change in ROE (Return on Equity) of Johnson & Johnson can be an indicator of the financial performance of the company and demonstrate how successful the company is compared to other companies in the same industry.

How to calculate the ROE (Return on Equity) of Johnson & Johnson?

The ROE (Return on Equity) is calculated by dividing the company's profit by the total equity. The formula is: ROE = Profit / Total equity.

Which factors influence the ROE (Return on Equity) of Johnson & Johnson?

Some factors that can influence Johnson & Johnson's Return on Equity (ROE) include the efficiency in using equity, the profitability of the company, and the financing structure.

What strategic measures can take to improve the ROE (Return on Equity)?

To improve the Return on Equity (ROE), can take measures such as cost savings, increasing revenue, improving efficiency in the use of equity, and making changes in the financing structure. It is important for the company to conduct a thorough review of its financial situation to determine the best strategic actions to improve ROE.

How much dividend does Johnson & Johnson pay?

Over the past 12 months, Johnson & Johnson paid a dividend of 4.7 USD . This corresponds to a dividend yield of about 3.22 %. For the coming 12 months, Johnson & Johnson is expected to pay a dividend of 5.1 USD.

What is the dividend yield of Johnson & Johnson?

The current dividend yield of Johnson & Johnson is 3.22 %.

When does Johnson & Johnson pay dividends?

Johnson & Johnson pays a quarterly dividend. This is distributed in the months of September, December, March, June.

How secure is the dividend of Johnson & Johnson?

Johnson & Johnson paid dividends every year for the past 63 years.

What is the dividend of Johnson & Johnson?

For the upcoming 12 months, dividends amounting to 5.1 USD are expected. This corresponds to a dividend yield of 3.49 %.

In which sector is Johnson & Johnson located?

Johnson & Johnson is assigned to the 'Health' sector.

Wann musste ich die Aktien von Johnson & Johnson kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Johnson & Johnson from 6/4/2024 amounting to 1.24 USD, you needed to have the stock in your portfolio before the ex-date on 5/20/2024.

When did Johnson & Johnson pay the last dividend?

The last dividend was paid out on 6/4/2024.

What was the dividend of Johnson & Johnson in the year 2023?

In the year 2023, Johnson & Johnson distributed 4.45 USD as dividends.

In which currency does Johnson & Johnson pay out the dividend?

The dividends of Johnson & Johnson are distributed in USD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

The Johnson & Johnson stock can be added to a savings plan with the following providers: Trade Republic, ING, Scalable Capital and Consorsbank

Andere Kennzahlen von Johnson & Johnson

Our stock analysis for Johnson & Johnson Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Johnson & Johnson Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.